PHIO Q3 2021 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$3M

Operating Income

-$4M

Net Income

-$4M

EPS (Diluted)

$-29.89

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$143,000

Balance Sheet

Total Assets

$28M

Total Liabilities

$3M

Stockholders' Equity

$25M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$3M	-$1M	-112.8%
Operating Income	-$4M	-$2M	-62.1%
Net Income	-$4M	-$2M	-62.1%